SCHEMBL19082330

SCHEMBL19082330

c1ccc(-c2c3ccccc3c(-c3ccc(-c4c5sc6ccccc6c5cc5c4sc4c6ccccc6ccc54)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.42
CYP1B1 Q16678 5/20 0.42
TNKS O95271 1/20 0.39
TNKS2 Q9H2K2 1/20 0.39
ALOX5 P09917 1/20 0.36
MAPT P10636 2/20 0.35
CYP1A2 P05177 4/20 0.35
F9 P00740 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
SOS1 Q07889 1/20 0.33
ATM Q13315 1/20 0.33
ESR1 P03372 2/20 0.32
ESR2 Q92731 2/20 0.32
GPR3 P46089 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
ALDH1A1 P00352 3/20 0.31
HPGD P15428 2/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082155 0.89 CYP1A1 (0.43) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL19082223 0.89 CYP1A1 (0.46) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL17944642 0.88 TNKS (0.47) TNKSTNKS2ALOX5MAPTF9
SCHEMBL19082350 0.88 CYP1A1 (0.42) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL17932039 0.85 CYP1A1 (0.44) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL19082119 0.85 ALOX5 (0.40) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL19082385 0.84 ALOX5 (0.41) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL19077372 0.84 TNKS (0.42) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL17932038 0.84 CYP1A1 (0.43) CYP1A1CYP1B1TNKSTNKS2ALOX5
SCHEMBL19082146 0.83 CYP1A1 (0.40) CYP1A1CYP1B1TNKSTNKS2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885TNKS 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.